Indication
Metastatic Esophageal
1 clinical trial
3 products
Clinical trial
Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2027-02-02
Product
LVGN3616